MPO and colitis: The reduced severity of colitis in MC-170073-treated mice given DSS was also associated with lower levels of both colonic MPO (Fig. 2E) and the proinflammatory cytokines IL-1β, IL-6, and TNF-α (Fig. 2, F–H).